The Battle for the Brain: Could Niacin Be the Key to Unlocking Glioblastoma Treatment? on October 4, 2026 Posted by
New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
The Hidden Cost of Shelf Life: New Study Links Common Food Preservatives to Cardiovascular Risk on October 2, 2026 Posted by
Understanding Obsessive-Compulsive Disorder: A Comprehensive Guide to Symptoms, Causes, and Modern Treatment on October 2, 2026 Posted by
The Battle for the Brain: Could Niacin Be the Key to Unlocking Glioblastoma Treatment? on October 4, 2026 Posted by
New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
Posted in Digital Health Tools The FDA in Flux: Dr. Marty Makary’s Departure, Ethical Quandaries, and the Future of Pharmaceutical Policy on June 4, 2026
Posted in Medical Innovations The Unraveling of the FDA: Lessons from the Resignation of Marty Makary on May 17, 2026 rifanmuazin
Posted in Digital Health Tools The End of an Era: Marty Makary Resigns as FDA Commissioner Amid Unprecedented Agency Volatility on May 14, 2026 rifanmuazin
Posted in Digital Health Tools A Tenure of Turbulence: Marty Makary Resigns as FDA Commissioner Amid Agency Instability on May 14, 2026 rifanmuazin
Posted in Digital Health Tools The Legacy of a Disrupted Agency: Analyzing the Tenure of FDA Commissioner Marty Makary on May 13, 2026 rifanmuazin
Posted in Caregiver Support The Tumultuous Tenure Ends: FDA Commissioner Dr. Marty Makary Resigns Amid Agency-Wide Crisis on May 12, 2026 rifanmuazin
Posted in Medical Innovations The Tumultuous Exit: Marty Makary Resigns as FDA Commissioner Amid Internal Strife and Political Pressure on May 12, 2026 rifanmuazin
Posted in Medical Innovations FDA Commissioner Marty Makary Set to Depart Amidst Growing Administrative Turbulence on May 9, 2026 rifanmuazin
